Biotech Eiger Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 9, 2023 to Discuss Your Rights – EIGR December 13, 2022
Biotech Bears are Losing Control Over Galectin Therapeutics Inc. (GALT), Here’s Why It’s a ‘Buy’ Now December 13, 2022
Biotech ContraFect Announces Pricing of $7.0 Million Registered Direct Offering and Concurrent Private Placement December 13, 2022
Biotech Eyenovia Announces FDA Acceptance of New Drug Application for MydCombi(TM) for In-Office Pupil Dilation December 13, 2022
Biotech Arbutus Completes Enrollment in its Phase 2a Clinical Trial Combining AB-729 with NA Therapy and Peginterferon alfa-2a in Patients with Chronic Hepatitis B Virus Infection December 13, 2022
Biotech ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV(TM) & BIVIGAM® December 13, 2022
Biotech ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2022 December 13, 2022
Biotech Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SolarEdge, Eiger, Unisys, and Rent and Encourages Investors to Contact the Firm December 12, 2022
Biotech Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eiger BioPharmaceuticals, Inc. (EIGR) December 12, 2022
Search
biotech
December 13, 2022
December 13, 2022
December 13, 2022
December 13, 2022
December 13, 2022
December 13, 2022
December 13, 2022
December 13, 2022
December 12, 2022
December 12, 2022
